Home › Funds › DeepCurrents Investment Group LLC › VRDN

DeepCurrents Investment Group LLC position in VRDN

VIRIDIAN THERAPEUTICS INC · Health Care

DeepCurrents Investment Group LLC reported holding 19,460,000 shares of VRDN (VIRIDIAN THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$22.3M, representing 0.74% of its reported portfolio and ranking #47 among its reported holdings. DeepCurrents Investment Group LLC has disclosed VRDN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)19.46M sh
Reported value held$22.26M
Portfolio Weight0.74%
First reportedQ2 2026
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How DeepCurrents Investment Group LLC's VRDN position evolved

DeepCurrents Investment Group LLC first disclosed a stake in VRDN in Q2 2026 at 11,960,000 shares (US$12.8M). The position peaked in Q3 2026 at 19,460,000 shares, worth US$22.3M. Across 2 filings, DeepCurrents Investment Group LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 19,460,000 shares valued at US$22.3M — an increase of 7,500,000 shares quarter over quarter.. Notable position changes include a 63% increase in Q3 2026 (shares rose 50% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 11.96M $12.78M New
Q3 2026 19.46M $22.26M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRDN and 13F data

VRDN (VIRIDIAN THERAPEUTICS INC) is a Health Care company. 35 other funds we track also report a position in VRDN — the largest reported positions include Bellevue Group AG (US$123.7M), Paradigm Biocapital Advisors LP (US$123.5M), Kynam Capital Management, LP (US$118.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRDN

All VRDN fund holders →

FAQ

How long has DeepCurrents Investment Group LLC held VRDN?

DeepCurrents Investment Group LLC has disclosed VRDN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is DeepCurrents Investment Group LLC's current position in VRDN?

As of Q3 2026, DeepCurrents Investment Group LLC holds 19.46M shares of VRDN (VIRIDIAN THERAPEUTICS INC), valued at $22.26M, representing 0.74% of its reported portfolio and ranking #47.

Has DeepCurrents Investment Group LLC been buying or selling VRDN?

In the latest 13F filing (Q3 2026), DeepCurrents Investment Group LLC increased its position in VRDN. The position peaked in Q3 2026 at 19.46M shares.

Which other funds hold VRDN?

Other major institutional holders of VRDN include Bellevue Group AG, Paradigm Biocapital Advisors LP, Kynam Capital Management, LP, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.